Reports from Jinan University Highlight Recent Findings in Breast Cancer (Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis)

Source :: Women's Health Weekly. September 17, 2020, 359
Publication Year :: 2020
Abstract: 2020 SEP 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in Oncology - Breast Cancer. According to news reporting out [...]

Subjects :: Anastrozole -- Research
Cost benefit analysis -- Economic aspects -- Research -- Analysis
Hormones -- Research -- Economic aspects -- Analysis
Women's health -- Research -- Analysis -- Economic aspects
Postmenopausal women -- Analysis -- Research -- Economic aspects
Fulvestrant -- Research
Breast cancer -- Research
Cancer metastasis -- Research
Cost benefit analysis
Health
Women's issues/gender studies

Tools